ClariVest Asset Management LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,980
+47.4%
51,338
+36.7%
0.16%
+58.8%
Q2 2023$2,022
-99.6%
37,546
+101.4%
0.10%
+385.7%
Q1 2022$524,000
-47.3%
18,643
-13.7%
0.02%
-32.3%
Q4 2021$995,000
+99400.0%
21,596
+50123.3%
0.03%
Q3 2021$1,000
-100.0%
43
-99.9%
0.00%
-100.0%
Q1 2015$2,536,000
+16.8%
40,550
+5.3%
0.08%0.0%
Q4 2014$2,172,000
+70.6%
38,524
-14.4%
0.08%
+63.8%
Q3 2014$1,273,000
-18.0%
45,001
-0.1%
0.05%
-20.3%
Q2 2014$1,552,000
-12.6%
45,036
-20.5%
0.06%
-18.1%
Q1 2014$1,775,00056,6140.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders